Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New insights into HLA class I association to Behçet's syndrome in Iranian Azari patients.

Auto- immunity highlights·2015
Same author

Methanolic Fractions of Ornithogalum cuspidatum Induce Apoptosis in PC-3 Prostate Cancer Cell Line and WEHI-164 Fibrosarcoma Cancer Cell Line.

Advanced pharmaceutical bulletin·2014
Same author

Effects of some natural immunomodulatory compounds in combination with thalidomide on survival rate and tumor size in fibrosarcoma-bearing mice.

Advanced pharmaceutical bulletin·2014
Same author

Interleukin-17 in human inflammatory diseases.

Postepy dermatologii i alergologii·2014
Same author

Echinophora platyloba DC (Apiaceae) crude extract induces apoptosis in human prostate adenocarcinoma cells (PC 3).

Biomedical journal·2014
Same author

Current challenges in metastasis: disseminated and circulating tumor cells detection.

Human antibodies·2014

Related Experiment Video

Updated: May 5, 2026

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

15.1K

Sensitive antibody-based CTCs detection from peripheral blood.

Fatemeh Zare Shahneh1

  • 1Department of Immunology, Tabriz University of Medical Sciences, Tabriz, Iran. Tel.: +98 912 1886793; Fax: +98 411 3364665;

Human Antibodies
|November 29, 2013
PubMed
Summary

Circulating tumor cells (CTCs) detection is crucial in oncology. Antibody-based methods enrich CTCs from blood, aiding biomarker discovery for cancer treatment and progression monitoring.

Keywords:
CTC detectionCirculating tumor cellsantibodiestumor biomarkers

More Related Videos

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.1K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

2.1K

Related Experiment Videos

Last Updated: May 5, 2026

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications

Published on: February 28, 2014

15.1K
Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence
10:29

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

10.1K
Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples
08:49

Automatic Separation and Collection of Cancer-Related Substances from Clinical Samples

Published on: January 13, 2023

2.1K

Area of Science:

  • Oncology
  • Biomedical Engineering
  • Molecular Diagnostics

Background:

  • Circulating tumor cells (CTCs) are shed from primary and metastatic tumors into the bloodstream.
  • Detecting CTCs is vital for understanding cancer metastasis and progression in patients with breast, prostate, lung, and colorectal cancers.
  • Current research focuses on CTCs as key biomarkers for cancer management.

Purpose of the Study:

  • To review antibody-based methods for enriching circulating tumor cells (CTCs).
  • To elucidate the role of CTC detection in advancing oncology research and clinical applications.
  • To highlight the potential of CTC biomarkers in predicting treatment response and disease progression.

Main Methods:

  • Review of antibody-based affinity techniques for CTC separation.
  • Discussion of enrichment strategies based on differential expression of tumor-specific cell surface markers.
  • Analysis of methods utilizing epithelial or hematopoietic cell antigens for CTC isolation.

Main Results:

  • Antibody-based affinity methods effectively separate CTCs from peripheral blood.
  • Specific antigen expression on tumor cells is key for enrichment strategies.
  • Advancements in CTC detection promise improved clinical applications and biomarker discovery.

Conclusions:

  • Antibody-driven CTC detection is a pivotal area in oncology research.
  • Improved CTC detection methods will enhance clinical applications and biomarker discovery for cancer.
  • Further development in CTC analysis will aid in predicting patient treatment response and disease outcomes.